Trial Profile
Phase III trial of alpha-1 antitrypsin (AAT) in patients with graft-versus-host disease
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2015
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Graft-versus-host disease
- Focus Registrational; Therapeutic Use
- Sponsors Kamada
- 25 Mar 2015 New trial record